Numerous studies (e.g. [23], [24]) show that increase in IL-10 produced by macrophages is associated with tumor progression, while other studies [25]–[28] suggest that IL-10 plays a positive role in tumor rejection. The gene discussed is IL10; the disease is neoplasm.